Trial intelligence / Profile preview

Oral Pulsed Methylprednisolone for Pediatric Intractable Epilepsy

NCT04219995Phase 2Unknown

Sponsor
Louisiana State University Health Sciences Center
Start
Feb 2020
Primary completion
Feb 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone sodium succinate in epilepsy, sponsored by Louisiana State University Health Sciences Center. Status: unknown.

02

Drugs

methylprednisolone sodium succinate
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT04219995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04219995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call